You are here

Resize Text
See all clinical trials

OPsumit USers Registry (OPUS)

Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.

Clinical Trial Information

Protocol
TIRB#: 24499, WIRB#: 20140816
Phase
n/a
Conditions
Pulmonary Arterial Hypertension
Investigator
Jeffrey I. Stewart, MD
Coordinator
Gayle Jones, RN and Danielle Vega, RN

Visit clinicaltrials.gov for full clinical trial description.

Contact

For more information about this trial or to inquire about eligibility, email breathe@temple.edu

Full Title

US-based, Observational, Drug Registry of Opsumit® (Macitentan) New Users in Clinical Practice